Independent Pharmacies Must Expand Services to Stay Afloat | AAP 2025
Drug Topics
APRIL 16, 2025
At AAP 2025, Douglas Hoey, RPh, MBA, CEO of NCPA, discussed what pharmacies can do to increase revenue and avoid shutting their doors.
Sat.Apr 12, 2025 - Fri.Apr 18, 2025
465 
RFK Jr. calls rising autism rate an ‘epidemic.’ Researchers call it a ‘good sign’
STAT
APRIL 15, 2025
A new federal report suggests that U.S. autism rates are rising modestly, an increase that health researchers said reflected expanded diagnostic tools and access to care, among other factors. But health secretary Robert F. Kennedy Jr. instead has pointed to the data as evidence of a growing crisis. The Centers for Disease Control and Prevention report says that 3.2% of kids surveyed in 2022 have autism spectrum disorder, a slight uptick from the 2.8% of kids surveyed in 2020 for the previous rep
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
A big moment is coming for psychedelics
PharmaVoice
APRIL 18, 2025
Compass Pathways expects to publish the first phase 3 results from a large-scale, psilocybin drug trial by the end of this quarter.
Mounjaro generic availability, cost, and more
The Checkup by Singlecare
APRIL 15, 2025
Many people are interested in generic drug availability since brand-name drugs are often costly. Mounjaro (tirzepatide) is a brand-name prescription medication that is approved by the Food and Drug Administration (FDA) to improve blood sugar levels in people with Type 2 diabetes. It is also commonly used off-label for weight loss because, as a dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist, tirzepatide helps control appetite
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Inflammatory Biomarker Linked to Type 2 Diabetes Shows Increased Risk of Liver Cancer
Drug Topics
APRIL 14, 2025
Furthermore, C-reactive protein has greater prognosis for lung cancer, colorectal cancer, and ovarian cancer.
Supreme Court to hear challenge to ACA rule requiring free preventive care, cancer screenings
STAT
APRIL 17, 2025
For a decade and a half, Americans have been guaranteed that no matter their health insurer, certain preventive care like cancer screenings are free of charge. That’s because an Affordable Care Act provision has required insurers to fully cover services given an A or B recommendation by an expert task force. That may soon change. On Monday, the U.S.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
From pipettes to processors: How AI Is reshaping pharma’s future
European Pharmaceutical Review
APRIL 17, 2025
Over the past decade, we have witnessed the arrival of a new era in biopharmaceutical R&D. Traditional methods and processes, such as wet labs, are being augmented by a rapidly expanding digital ecosystem in pharma. Across the industry, this shift is offering extraordinary opportunities to increase the speed, accuracy, and reproducibility of research.
National Association of Attorneys General Urges Congress to Prohibit PBM-Owned Pharmacies
Drug Topics
APRIL 15, 2025
On behalf of 39 state and territory attorneys general, the National Association of Attorneys General issued a letter to Congress regarding major PBMs conflicts of interest.
STAT+: Tennessee officials find Express Scripts violated law governing commercial pharmacy claims
STAT
APRIL 13, 2025
In an unusual move, an audit of commercial health plans by Tennessee officials found that Express Scripts, one of the largest pharmacy benefit managers in the United States, violated state laws in its dealings with pharmacies, according to newly released documents. Specifically, the company failed to properly reimburse pharmacies, favored its own specialty pharmacy operations by paying higher dispensing fees than to other pharmacies, and did not properly handle appeals filed by pharmacies, accor
Amid an onshoring push, Raleigh is poised to be pharma’s next manufacturing hub
PharmaVoice
APRIL 16, 2025
Lower operating costs and a supply of high-skilled workers are helping the North Carolina region pull in billions of pharma manufacturing investments.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
What is Data-Driven Marketing in Pharma
Pharma Marketing Network
APRIL 16, 2025
Imagine launching a brand campaign without guessworkwhere your message reaches the right healthcare professional at the right time on the right channel. Thats the promise of data-driven marketing , a strategy thats rapidly transforming how pharmaceutical companies approach promotion, education, and engagement in 2025. As privacy regulations evolve, customer expectations change, and AI-driven technologies emerge, pharma marketers must adapt or risk becoming irrelevant.
Independent Pharmacies Must Be Prepared For DEA Inspections | AAP 2025
Drug Topics
APRIL 14, 2025
At AAP 2025, Ron Friedman discussed best practices for responding to a DEA inspection, how to identify any red flags, and best practices for dispensing.
STAT+: Attorneys general want Congress to prohibit PBMs from owning affiliated pharmacies
STAT
APRIL 14, 2025
Dozens of state attorneys general are urging Congress to pass a law prohibiting pharmacy benefit managers from simultaneously owning pharmacies, arguing such a move would boost competition and create more affordable prescription drug prices for Americans. Their concern is these arrangements create conflicts of interest that allow pharmacy benefits managers to dominate the design of health plans for tens of millions of Americans, and also distort the distribution and pricing for prescription medi
Novartis scores NFL deal to tackle health outcomes
PharmaVoice
APRIL 17, 2025
The non-traditional marketing approach comes amid a potential crackdown on TV drug ads.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Why Pharma’s Digital Ad Spend Will Surge Amid Tariff Fears and TV Ad Uncertainty
Pharma Marketing Network
APRIL 17, 2025
What do you do when the traditional pillars of your marketing strategy start to crumble? For many pharmaceutical companies in 2025, the answer is clear: pivot aggressively toward digital. With geopolitical volatility sparking new tariff threats and mounting legislative scrutiny over pharmaceutical television ads, pharma digital ad spend is experiencing a noticeable surge.
FDA Grants Yuflyma Interchangeability Designation for Humira
Drug Topics
APRIL 15, 2025
The FDA approved adalimumab-aaty in May 2023 for 8 indications, including rheumatoid arthritis, psoriatic arthritis, Crohn disease, ulcerative colitis, and plaque psoriasis.
STAT+: Daily pill from Eli Lilly helps patients control blood sugar, lose weight, Phase 3 study shows
STAT
APRIL 17, 2025
A daily pill from Eli Lilly helped patients with type 2 diabetes improve their blood sugar and shed weight, the company said Thursday, results that could propel the next-generation treatment onto the market. The drug, orforglipron, produced results that were nearly comparable to the benefits of available GLP-1 drugs, which are weekly injectable treatments.
The essential role of hospital pharmacists in the CAR T-cell supply chain
Hospital Pharmacy Europe
APRIL 17, 2025
As an overall patient safety and medicines quality measure, hospital pharmacists in Belgium have mitigated critical risks in the supply chain for chimeric antigen receptor (CAR) T-cell therapies. Advanced therapy medicinal products (ATMPs), such as CAR T-cell therapies, are innovative biological drugs that demand careful management of complex supply chains.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
COVID-19 Associated With Higher Risk of Postacute Kidney Outcomes in Pediatric Patients With Preexisting CKD
Pharmacy Times
APRIL 16, 2025
At 28 to 179 days, COVID-19 infection in patients with preexisting chronic kidney disease (CKD) was associated with an increased risk of composite kidney events.
Pfizer Discontinues Development of Investigational Oral GLP-1 for Weight Management
Drug Topics
APRIL 15, 2025
One asymptomatic patient did experience drug-induced liver injury that was resolved after discontinuation of danuglipron.
Opinion: Dismantling the one U.S. agency focused on older adults, people with disabilities is startlingly inefficient
STAT
APRIL 17, 2025
Even before the Department of Health and Human Services announced its recent major reorganization, the media had been reporting on anticipated changes to the Centers for Disease Control and Prevention, the Food and Drug Administration, and the National Institutes of Health. But the very last bullet on the HHS fact sheet was a complete surprise to most people: the elimination of the Administration for Community Living (ACL).
The fallout from UnitedHealth’s CEO slaying
PharmaVoice
APRIL 15, 2025
Brian Thompson’s murder has raised questions about the cost of U.S. healthcare, embroiling insurers, drugmakers and PBMs in a battle for the future of the industry.
What causes rapid weight gain? Related conditions and treatments
The Checkup by Singlecare
APRIL 17, 2025
Overview: What does rapid weight gain look like? So, the numbers on the scale took a recent jump. Most people will experience some type of weight gain over their lifetimeand smaller weight fluctuations are very commonbut it can be slightly more alarming when the pounds start to add up quickly. Theres no overarching clinical definition, although a noticeable increase in body weight over a few days or weeks is typically cause for alarm and further investigation.
Skin of Color Dermatology Substantially Improved in Last 20 Years
Drug Topics
APRIL 16, 2025
Over 20 years since skin of color dermatology was introduced, researchers explored advancements and what is yet to come in the future.
STAT+: Makary says FDA will remove pharma representatives from advisory panels
STAT
APRIL 17, 2025
WASHINGTON — The Food and Drug Administration will remove industry representatives from advisory committees and replace them with patients and caregivers, Commissioner Marty Makary announced Thursday. While that’s not really a big change, it’s the latest effort by Makary and his boss, health secretary Robert F. Kennedy Jr., to reduce the influence of the pharmaceutical industry.
New drug delivery method for cell therapies reported
European Pharmaceutical Review
APRIL 17, 2025
Researchers in Spain have developed a new method to deliver cell therapies to patients on extracorporeal membrane oxygenation (ECMO), a life support system for severe lung failure. The consecutive intrabronchial administration (CIBA) method enables a new route of delivery: targeted, controlled, fractionated intrabronchial delivery. The researchers referred to the novel approach as slow consecutive intrabronchial lobe-by-lobe administration.
Content Marketing Strategies Used in Pharma Marketing
Pharma Marketing Network
APRIL 16, 2025
If your brand still views content as a checkbox for SEO or a static digital asset, you’re already falling behind. In the ever-evolving healthcare landscape, especially in 2025, content marketing strategies have moved from optional to mission-critical for pharma brands. But not just any content will do. Today, successful campaigns are dynamic, identity-driven, omnichannel, and personalized.
Pharmacists Play Crucial Role in Managing Women’s Heart Health
Drug Topics
APRIL 16, 2025
Katherine Tromp, PharmD, interim dean at Northeast Ohio Medical University College of Pharmacy, discusses how pharmacists can help prevent heart disease in women.
Vaccine advisory panel, a frequent target of Kennedy, meets with little drama
STAT
APRIL 15, 2025
A meeting of vaccine advisers long targeted by Health Secretary Robert F. Kennedy Jr. unfolded Tuesday seemingly without fireworks or interference, although the new administration’s imprint could be seen from the start, when staff for the Centers for Disease Control and Prevention, gutted by layoffs, struggled to get a livestream running.
Does Aetna cover Saxenda?
The Checkup by Singlecare
APRIL 17, 2025
Saxenda ( liraglutide ) is a brand-name glucagon-like peptide-1 ( GLP-1 ) agonist made by the pharmaceutical company Novo Nordisk. It is approved by the U.S. Food and Drug Administration (FDA) for chronic weight management in adults with a starting, or baseline , body mass index ( BMI ) of 30 or more ( obesity ). It can also be used in adults with a starting BMI of 27 or more (overweight) with at least one weight-related health condition, such as high blood pressure , Type 2 diabetes , or dyslip
Enforcement Under the New FDA: HPM to Host a Q&A Webinar on FDC Act Enforcement with Three Former Federal Prosecutors
The FDA Law Blog
APRIL 16, 2025
By Andrew J. Hull & JP Ellison & John W.M. Claud Hyman, Phelps & McNamara, P.C. is hosting a free webinar on recent and forward-looking enforcement under the Federal Food, Drug & Cosmetic Act on Thursday, May 1, 2025, from 12:00 p.m. to 1:30 p.m. (ET) (register here ). Join us as HPMs Anne Walsh moderates a panel discussion with three former DOJ attorneys who all litigated extensively under the FDCA.
FDA Approves Diazepam Nasal Spray for Treatment of Seizure Clusters in Pediatric Patients
Drug Topics
APRIL 16, 2025
The drug is approved for the short-term treatment of acute repetitive seizures, also known as seizure clusters, which differ from a patients normal seizure pattern.
STAT+: GSK blood cancer therapy, once pulled from the market, is approved in the U.K.
STAT
APRIL 17, 2025
GSK’s blood cancer drug Blenrep won regulatory approval in the U.K. on Thursday, marking the medicine’s return to the market after it was withdrawn several years ago. The drug, which treats multiple myeloma, will be used in combination with other medicines in patients whose cancer has resurged after an earlier line of treatment, under the approval from the Medicines and Healthcare products Regulatory Agency.
Let's personalize your content